A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients

V.B.C. Biemans, E. Savelkoul, R.Y. Gabriels, M. Simsek, G. Dijkstra, M.J. Pierik, R.L. West, N.K.H. de Boer, F. Hoentjen*, Dutch Initiative on Crohn and Colitis (ICC)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1076-1086
Number of pages11
JournalAlimentary Pharmacology & Therapeutics
Volume51
Issue number11
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • adverse events
  • azathioprine
  • combination therapy
  • crohns-disease
  • efficacy
  • infliximab
  • intensification
  • prevalence
  • safety
  • thioguanine
  • CROHNS-DISEASE
  • EFFICACY
  • SAFETY
  • COMBINATION THERAPY
  • AZATHIOPRINE
  • PREVALENCE
  • INTENSIFICATION
  • THIOGUANINE
  • INFLIXIMAB
  • ADVERSE EVENTS

Cite this